Alan Williams

Nessuna posizione attualmente

Health Technology

Electronic Technology

Consumer Services

Precedenti posizioni note di Alan Williams

Società	Posizione	Inizio	Fine
AFFYMETRIX, INC.	Corporate Officer/Principal	01/01/2000	-
Neomorphics, Inc. Neomorphics, Inc. Medical SpecialtiesHealth Technology Neomorphics, Inc. develops, analyzes, and manages genetic information to improve disease. The company is based in Berkeley, CA. The company was founded by Cyrus L. Harmon, Martin G. Reese. Neomorphics was acquired by Affymetrix, Inc., part of Thermo Fisher Scientific, Inc. from April 01, 2016 on October 31, 2000 for $85.92 million.	Corporate Officer/Principal	-	-
Ion Torrent Systems, Inc. Ion Torrent Systems, Inc. SemiconductorsElectronic Technology Ion Torrent Systems, Inc. develops semiconductor chips for DNA sequencing systems. The company was founded in 2007 and is headquartered in Guilford, CT.	Corporate Officer/Principal	31/08/2010	-

University of California, Berkeley

Doctorate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Corporate Officer/Principal	3
Doctorate Degree	1
Undergraduate Degree	1

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	3
Affymetrix, Inc. Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA.	Health Technology
Ion Torrent Systems, Inc. Ion Torrent Systems, Inc. SemiconductorsElectronic Technology Ion Torrent Systems, Inc. develops semiconductor chips for DNA sequencing systems. The company was founded in 2007 and is headquartered in Guilford, CT.	Electronic Technology
Neomorphics, Inc. Neomorphics, Inc. Medical SpecialtiesHealth Technology Neomorphics, Inc. develops, analyzes, and manages genetic information to improve disease. The company is based in Berkeley, CA. The company was founded by Cyrus L. Harmon, Martin G. Reese. Neomorphics was acquired by Affymetrix, Inc., part of Thermo Fisher Scientific, Inc. from April 01, 2016 on October 31, 2000 for $85.92 million.	Health Technology